These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3108638)

  • 1. Treatment of lymphohistiocytic erythrophagocytosis with VP-16 and aziridinylbenzoquinone.
    Becton DL; Kurtzberg J; Kinney TR; Friedman HS; Chaffee S; Falletta JM
    Med Pediatr Oncol; 1987; 15(2):58-61. PubMed ID: 3108638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of aziridinylbenzoquinone in refractory lymphoma.
    Case DC; Hayes DM
    Cancer Treat Rep; 1983 Nov; 67(11):993-6. PubMed ID: 6357437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
    Falletta JM; Shuster JJ; Crist WM; Pullen DJ; Borowitz MJ; Wharam M; Patterson R; Foreman E; Vietti TJ
    Leukemia; 1992 Jun; 6(6):541-6. PubMed ID: 1602793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose methotrexate-based chemotherapy as treatment for histiocytic sarcoma of the central nervous system.
    Curry RC; Faivre G; Akkari L; Joyce JA; Lin O; Rosenblum M; Diamond EL; Fisher R; Omuro A
    Leuk Lymphoma; 2016 Aug; 57(8):1961-4. PubMed ID: 26727454
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child.
    Iwabuchi H; Kawashima H; Umezu H; Takachi T; Imamura M; Saitoh A; Ogose A; Imai C
    Int J Hematol; 2017 Aug; 106(2):299-303. PubMed ID: 28247189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.
    Heath JL; Burgett SE; Gaca AM; Jaffe R; Wechsler DS
    Pediatr Blood Cancer; 2014 Oct; 61(10):1874-6. PubMed ID: 24888336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation.
    Fischer A; Virelizier JL; Arenzana-Seisdedos F; Perez N; Nezelof C; Griscelli C
    Pediatrics; 1985 Aug; 76(2):263-8. PubMed ID: 3839578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
    Tan CT; Hancock CH; Mondora A; Hoffman NW
    Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.
    Belasco JB; Luery N; Scher C
    Cancer; 1990 Dec; 66(12):2492-7. PubMed ID: 2249189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage of relapsed malignant histiocytosis by autologous bone marrow transplant.
    Berry J; Russell JA
    Bone Marrow Transplant; 1989 Jan; 4(1):123-4. PubMed ID: 2466511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
    Crist W; Shuster J; Look T; Borowitz M; Behm F; Bowman P; Frankel L; Pullen J; Krance R; Steuber P
    Leukemia; 1992; 6 Suppl 2():162-6. PubMed ID: 1578922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia.
    Winick NJ; Bowman WP; Kamen BA; Roach ES; Rollins N; Jacaruso D; Buchanan GR
    J Natl Cancer Inst; 1992 Feb; 84(4):252-6. PubMed ID: 1734087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213.
    Ambruso DR; Hays T; Zwartjes WJ; Tubergen DG; Favara BE
    Cancer; 1980 May; 45(10):2516-20. PubMed ID: 7378987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aziridinylbenzoquinone (AZQ) treatment of central nervous system leukemia.
    Kamen BA; Holcenberg JS; Siegel SE
    Cancer Treat Rep; 1982 Dec; 66(12):2105-6. PubMed ID: 6958367
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol.
    Atra A; Gerrard M; Hobson R; Imeson JD; Ashley S; Pinkerton CR
    Br J Cancer; 1998 Jun; 77(12):2281-5. PubMed ID: 9649146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant histiocytosis: study of 8 cases].
    Fernández Miranda C; Martínez González MA; Ricard P; Ballestín C; Asso A; Hernández Martínez E; Guerra J; del Palacio A
    Med Clin (Barc); 1988 Mar; 90(11):437-42. PubMed ID: 2455200
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanoma.
    Creagan ET; Schutt AJ; Ahmann DL; Green SJ
    Cancer Treat Rep; 1982 Dec; 66(12):2089-90. PubMed ID: 7139650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia.
    Meyers PA; Tan CT; Steinherz PG; Redner A
    Cancer; 1989 Dec; 64(12):2416-9. PubMed ID: 2479459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.